Donanemab, a monoclonal antibody similar to its predecessors, aducanumab (Aduhelm) and lecanemab (Leqembi), targets plaques in the brain formed by the protein amyloid.

A genetic mutation associated with a heightened risk of diseases, including Alzheimer’s and cardiovascular disease, apparently does more than meets the eye.

Researchers report meaningful progress in developing a new digital biomarker for detecting early signs of Alzheimer’s disease in brain wave patterns.

Heading off to college? You may want to pick up one of the best air purifiers for college dorms to make sure your new pad is top-notch.

Researchers in Sweden found that up to two in three cancer drugs prove to be useless for patients after years of research.

Teen smoking and nicotine addiction display a concerning link to shrinking brain volume, a new study warns.